Fundraising Fox

Aura Biosciences

NASDAQ: AURA

Cambridge, US · Delaware corporation · 10 known investors

aurabiosciences.com ↗
Biotechin /aurabiosciences@aurabiosciences

Founders & leadership

RP
Raj Parekh, Ph.D.Director
MW
Michael WyzgaExecutive Officer
JJ
Joel Jean-Mairet, Ph.D.Director
JB
Jose' Baselga, Ph.D.Director
DP
Dale Pfost, Ph.D.Director
AE
Alan E. Walts, Ph.D.Director
ED
Elisabet de los Pinos, Ph.D.Executive Officer, Director
LG
Lewis GeffenExecutive Officer
PW
Peter WirthDirector
AP
Art PappasDirector

Investors · 10

Advent Life SciencesLondon
Chiesi VenturesBoston · $5M
Jazzya InvestmentsAlcobendasvia Martin Varsavsky · inferred
MedicxiLondon
Myelin VCMontevideo · $250K – $1Mvia Matias Nisenson · inferred
OrbiMedNew York · $1M – $75M
venBio PartnersSan Francisco
Ysios CapitalBarcelona · $5.4M – $21.6M
Columbus Venture PartnersreportedBarcelonavia Jose Mesa · inferred
Droia VenturesreportedLeuven · $540K

Reported raises · per SEC filings

Form D private placements
▶$80.5MraisedApr 2021 · 41 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Karan TakharDirector
  • Julie FederExecutive Officer
  • Raj Parekh, Ph.D.Director
  • Elisabet de los Pinos, Ph.D.Executive Officer, Director
  • Giovanni Mariggi, Ph.D.Director
  • David JohnsonDirector
Offering amount
$80.5M
Amount sold
$80.5M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedJul 2020 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christian SchetterDirector
  • Elisabet de los Pinos, Ph.D.Executive Officer, Director
  • Raj Parekh, Ph.D.Director
  • Giovanni Mariggi, Ph.D.Director
  • Julie FederExecutive Officer
  • George Golumbeski, Ph.D.Director
  • Art PappasDirector
  • Joel Jean-Mairet, Ph.D.Director
  • Casper BreumDirector
Offering amount
$17M
Amount sold
$10M
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedApr 2019 · 36 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Raj Parekh, Ph.D.Director
  • Casper BreumDirector
  • Art PappasDirector
  • Julie FederExecutive Officer
  • Lewis GeffenExecutive Officer
  • Giovanni Mariggi, Ph.D.Director
  • Joel Jean-Mairet, Ph.D.Director
  • Elisabet de los Pinos, Ph.D.Executive Officer, Director
  • Alan E. Walts, Ph.D.Director
  • Mark ChinDirector
Offering amount
$40M
Amount sold
$20M
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$42.3MraisedDec 2018 · 42 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lewis GeffenExecutive Officer
  • Casper BreumDirector
  • Julie E. FederExecutive Officer
  • Dale Pfost, Ph.D.Director
  • Mark ChinDirector
  • Art PappasDirector
  • Elisabet de los Pinos, Ph.D.Executive Officer, Director
  • Joel Jean-Mairet, Ph.D.Director
  • Alan E. Walts, Ph.D.Director
Offering amount
$42.5M
Amount sold
$42.3M
First sale
Dec 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.5MraisedNov 2017 · 38 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Raj Parekh, Ph.D.Director
  • Michael WyzgaExecutive Officer
  • Joel Jean-Mairet, Ph.D.Director
  • Jose' Baselga, Ph.D.Director
  • Dale Pfost, Ph.D.Director
  • Alan E. Walts, Ph.D.Director
  • Elisabet de los Pinos, Ph.D.Executive Officer, Director
  • Lewis GeffenExecutive Officer
  • Peter WirthDirector
  • Art PappasDirector
Offering amount
$11.5M
Amount sold
$11.5M
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21MraisedMar 2015 · 21 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Peter B. FinnExecutive Officer
  • Alan Walts, Ph.D.Director
  • Elisabet de los Pinos, Ph.D.Executive Officer, Director
  • Peter WirthDirector
  • Javier GarciaDirector
  • Joel Jean-Mairet, Ph.D.Director
  • Art PappasDirector
  • Jose Baselga, Ph.D.Director
  • Dale Pfost, Ph.D.Director
Offering amount
$34.5M
Amount sold
$21M
Minimum investment
$25K
Proceeds to insiders
$1.2M
First sale
Feb 2015
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.